European Initiative for Quality in Thoracic Oncology (EIQTOC): A systematic review and guideline on various aspects of quality in thoracic oncology care

TF-2014-27

This Task Force aims to develop a clinical practice guideline based upon a high-level systematic review on various aspects of quality in thoracic oncology care. This document intends to complete the previous narrative literature search developed by the ERS that showed little high-level evidence in this field of interest. The representation of all relevant professions/disciplines in the thoracic oncology care trajectory as well as active patient involvement are fundamental elements of the project concept.

ERS-EACTS-ESTS-ESTRO Guidelines for the management of Malignant Pleural Mesothelioma patients

TF-2014-23

Previously considered as a rare tumor, malignant pleural mesothelioma (MPM) has become a very important public health issue. MPM is a tumor with a poor survival and its diagnosis may be difficult because of differential diagnosis such as pleural benign disease induced by asbestos exposure or pleural metastasis of adenocarcinoma. Management of patients with MPM also remains complicated because they are often referred for evaluation late in the evolution of the disease. The aim of this Task Force is therefore to provide clinicians with new concise, up-to-dated clinical practice guidelines on management of MPM.

Functional evaluation of lung and airways: building a flow chart for a comprehensive, multifaceted, evidence-based use of the different techniques

TF-2013-13

Functional evaluation of airway and lung function is still dominated by traditional tests like spirometry, single or multiple breath wash-in/washout and lung diffusion. During the last years, however, a large amount of evidence has been produced regarding the use of alternative approaches for a more complete understanding of lung and airways function in health and diseases.

Guidelines for the management of Hospital acquired pneumonia

TF-2012-14

Hospital Acquired Pneumonia (HAP) and Ventilator Associated Pneumonia (VAP) are the second intrahospital infection carrying a very high morbidity, mortality, and sanitary costs. In the last 5 years a lot of information has been released in the literature as regards ethiopathogenesis, etiology, diagnosis, treatment and prevention of these entities. This new information could motivate changes in clinical practice.

Exercise testing as an outcome of therapeutic interventions

TF-2012-08

Exercise intolerance is one, if not the most, of the deleterious consequences of pulmonary diseases that has a great impact on patients’ quality of life. Moreover, exercise tolerance is independently related to mayor outcomes such as survival, rate of hospital admissions and overall cost of pulmonary diseases such as COPD. Thus, because exercise tolerance is an important outcome and its assessment, while complex, will result in a better management of patients. Moreover, measuring exercise tolerance is becoming a very relevant issue for both medical practice and in clinical trials.

Long term management of bronchopulmonary dysplasia

TF-2015-18

Bronchopulmonary dysplasia (BPD) isachroniclungdisease thatmostcommonly occurs after preterm birth.Theincidence ofBPD hasnot declined over the pastdecade butthe severity and the clinical course of BPD have·changed with current advanced neonatal practice, leading to a new form of BPD.

Assessment of pulmonary exercise hemodynamics

TF-2014-25

The assessment of pulmonary exercise hemodynamics provides important clinical information in patients with respiratory and cardiac diseases. Alterations may represent early forms of pulmonary vascular diseases or latent pulmonary and cardiac dysfunction. An increasing number of studies dealing with pulmonary exercise hemodynamics have been performed in recent years.

 

Statement on Electronic Cigarettes

TF-2014-22

The number of individuals that use electronic cigarettes (EC) is quickly increasing. In contrast, only very limited data on the potential harmful effects of ECs' or on their potential usefulness for smoking cessation or harm reduction are available. It is the aim of this TF to collect the results from research on various health-related aspects of EC, to identify gaps in our knowledge of EC, and to make recommendations for filling these gaps.

Household Air Pollution from Solid Fuel Combustion Smoke and Global Health Equality

TF-2014-18

The workshop objectives are to ensure that upon conclusion, participants will be able to explain health effects by solid fuel smoke exposure in developed and developing countries; identify components of solid fuel smoke and biomarkers of smoke exposure; understand mechanisms related to cardiopulmonary diseases due to solid fuel smoke exposure; and describe useful intervention strategies for developed and developing countries.

Diagnosis and management of idiopathic pulmonary fibrosis: a statement

TF-2014-08

Clinicians have struggled to apply the 2011 ATS/ERS/JRS/ALAT guideline for the diagnosis and management of idiopathic pulmonary fibrosis (IPF). In up to 50% of IPF patients, the diagnosis of IPF cannot be made without a surgical biopsy. However, it now appears that treatments used for alternative diagnosis may be actively damaging in IPF. 

Telemonitoring of ventilator-dependent patients

TF-2013-10

This Task force will establish an European network of clinical experts in HMV to analyse through a survey the current status of services for ventilator-dependent patients and provide a document on appropriate standard procedures, equipment and facilities.

Exhaled biomarkers in lung disease

TF-2012-11

Breath chemical tests consist of wide variety of measurements from the FDA approved exhaled nitric oxide (FENO) measurement to volatile organic compound determination and non-volatile biomarker profiling in the cooled breath sample called exhaled breath condensate (EBC).

Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep

TF-2012-01

The complexity of sleep related breathing disorders has been realized more and more clearly in recent years. Patients present with relevant comorbidities to sleep physicians, especially heart failure, atrial fibrillation, arterial hypertension, stroke. We see developments in medical practice, including the increasing use of opioids for chronic pain, and realize epidemiologic changes, such as the increasing population of obese persons.

 

ERS Statement on Respiratory Muscle Testing at Rest and during Exercise

TF-2016-06

Respiratory muscle function is a major clinical concern not only for respiratory diseases but also for neuromuscular disorders, intensive care or sports medicine for instance. Respiratory muscle testing is therefore of critical importance for patient diagnosis, follow-up and for evaluating the effect of various interventions aiming to improve the respiratory function. 

Interventional bronchoscopy in children

TF-2015-09

Interventional bronchoscopy includes associated techniques such as bronchoalveolar lavage, endobronchial and transbronchial biopsies, laser, tracheostomy, endoscopic intubationclosure of bronchopleural fistula, foreign body extraction, bronchial stent placement, drug application, and endobronchial ultrasound.

Statement on management of lung disease associated with alpha-1 antitrypsin deficiency

TF-2015-01

Although Alpha-1-Antitrypsin Deficiency (AATD) is recognised as a genetic predisposition to emphysema it has been over 10 years since the writing of the last Guidelines. Since then a large descriptive literature and a small number of therapeutic clinical trials have been undertaken. The project of this Task Force is to bring together European expertise in the diagnosis, interpretation of results, patient assessment and management of the disease. This will provide state of the art information for healthcare workers and patients.

Standarization of the single-breath determination of nitric oxide uptake in the lung

TF-2014-24

Pulmonary diffusing capacity for nitric oxide (DLNO) is a test to measure alveolar capillary membrane conductance. It was developed in the early 1980's by and postulated that by inhaling a small quantity of nitric (NO) and carbon monoxide (CO) together when preforming a diffusing capacity manoeuvre, all the components of diffusing capacity can be obtained simultaneously. Since then, the measurement of DLNO has been made in several studies. As it is nearly 30 years since the inception of DLNO, there are a lot of methodological issues concerning its measurement. It is the objective, therefore, to create a task force that will define the measurement of DLNO throughout the world.

 

MDR TB Guidelines

TF-2014-21

This Task Force intends to develop a document guiding the treatment of TB in settings where mycobacterial cultures, drug susceptibility testing, radiographic facilities, a2nd second-line drugs are routinely available

ATS/ERS Statement on Technical Standards for The Forced Oscillation Technique

TF-2014-17

This Task Force aims to update the document “The forced oscillation technique in clinical practice: methodology recommendations and future developments” published in 2003 in ERJ which summarised the technology at that time, recommended hardware specifications, summarised the clinical data for FOT to inform clinicians and suggested useful areas of need in clinical research.

 

Optimizing experimental research in respiratory diseases

TF-2014-05

This Task Force proposal is based on an ERS Research Seminar entitled “Optimizing disease models for lung diseases and drug development”. The concluding remarks of the seminar were that "animal models are critical to understand mechanisms and pathogenesis of pulmonary health and disease, and are indispensable for drug development".